HIV persistence in tissues on dolutegravir-based therapy is not associated with resistance mutations to dolutegravir
{{output}}
Background: Relatively few studies have investigated HIV-1 persistence in tissues, especially in healthy people-living-with-HIV-1 (PLWH) on a successful antiretroviral regimen containing second generation integrase inhibitors. ... ...
